DICE Therapeutics, Inc.

NasdaqGM:DICE Lagerbericht

Marktkapitalisierung: US$2.3b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

DICE Therapeutics Management

Management Kriterienprüfungen 2/4

We currently do not have sufficient information about the CEO.

Wichtige Informationen

J. Judice

Geschäftsführender

US$5.8m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts9.4%
Amtszeit als Geschäftsführer10yrs
Eigentum des Geschäftsführers1.7%
Durchschnittliche Amtszeit des Managements2.6yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder2.7yrs

Jüngste Management Updates

Recent updates

We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate

May 14
We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate

DICE Therapeutics positive phase 1 data for psoriasis candidate leads shares 71% higher

Oct 11

Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation

Sep 11
Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation

DICE Therapeutics GAAP EPS of -$0.58

Aug 11

DICE Therapeutics initiated at buy at Wainwright on platform for small molecule drugs

Jul 18

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von J. Judice im Vergleich zu den Einnahmen von DICE Therapeutics verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2023n/an/a

-US$104m

Mar 31 2023n/an/a

-US$91m

Dec 31 2022US$6mUS$540k

-US$84m

Sep 30 2022n/an/a

-US$77m

Jun 30 2022n/an/a

-US$74m

Mar 31 2022n/an/a

-US$59m

Dec 31 2021US$6mUS$465k

-US$49m

Sep 30 2021n/an/a

-US$40m

Jun 30 2021n/an/a

-US$29m

Mar 31 2021n/an/a

-US$27m

Dec 31 2020US$637kUS$437k

-US$24m

Vergütung im Vergleich zum Markt: J.'s total compensation ($USD5.77M) is about average for companies of similar size in the US market ($USD5.11M).

Entschädigung vs. Einkommen: J.'s compensation has increased whilst the company is unprofitable.

Geschäftsführer

J. Judice (59 yo)

10yrs

Amtszeit

US$5,773,577

Vergütung

Dr. J. Kevin Judice, Ph D., founded DiCE Molecules SV, Inc. (formerly known as DiCE Molecules Corp). and serves as its Chief Executive Officer, President and Secretary. Dr. Judice has extensive experience...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
J. Judice
Founder10yrsUS$5.77m1.67%
$ 38.0m
Scott Robertson
Chief Business & Financial Officer5.7yrsUS$2.67m0.41%
$ 9.4m
Timothy Lu
Chief Medical Officer3yrsUS$2.72m0.32%
$ 7.2m
John Jacobsen
Chief Scientific Officer2.2yrsUS$714.79k0.31%
$ 7.0m
Mary Riley
General Counsel1.4yrskeine Datenkeine Daten
Venkat Thalladi
Senior Vice President of CMC2.2yrskeine Datenkeine Daten
Paul Fatheree
Senior Vice President of Medicinal Chemistryno datakeine Datenkeine Daten

2.6yrs

Durchschnittliche Betriebszugehörigkeit

54yo

Durchschnittliches Alter

Erfahrenes Management: DICE's management team is considered experienced (2.6 years average tenure).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
J. Judice
Founderno dataUS$5.77m1.67%
$ 38.0m
Sharon Tetlow
Independent Director2.8yrsUS$264.90k0.10%
$ 2.4m
Richard Scheller
Independent Chairman of the Board7.7yrsUS$371.88k0.018%
$ 400.6k
James Scopa
Independent Director2.8yrsUS$264.90k0.086%
$ 1.9m
Mittie Doyle
Independent Director1.4yrsUS$552.51k0%
$ 0
Jake Simson
Independent Director2.7yrsUS$231.45kkeine Daten
Lisa Bowers
Independent Director1.4yrsUS$552.51k0%
$ 0

2.7yrs

Durchschnittliche Betriebszugehörigkeit

59yo

Durchschnittliches Alter

Erfahrener Vorstand: DICE's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.